Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|November 15, 2011
Prodrugs in photodynamic anticancer therapyRobert Musiol, Maciej Serda, Jaroslaw Polanski
Advanced Healthcare Materials|March 21, 2023
Recent Advancements on Self-Immolative System Based on Dynamic Covalent Bonds for Delivering Heterogeneous PayloadsQingbing Wang, Maciej Serda, Quan Li, et al.
International Journal of Molecular Sciences|October 16, 2024
Iron Metabolism in Aminolevulinic Acid-Photodynamic Therapy with Iron Chelators from the Thiosemicarbazone GroupRobert Gawecki, Patrycja Rawicka, Marta Rogalska, et al.
Drug Discovery Today|July 15, 2023
Interactions between modified fullerenes and proteins in cancer nanotechnologyMaciej Serda, Julia Korzuch, Dominik Dreszer, et al.
ACS Biomaterials Science & Engineering|July 20, 2022
In Situ Cellular Localization of Nonfluorescent [60]Fullerene Nanomaterial in MCF-7 Breast Cancer CellsMaciej Serda, Katarzyna Malarz, Julia Korzuch, et al.
Nanotoxicology|December 31, 2024
Investigation of potential cytotoxicity of a water-soluble, red-fluorescent [70]fullerene nanomaterial in Drosophila melanogasterMagdalena Rost-Roszkowska, Anna Urbisz, Karol Małota, et al.
Oncotarget|May 1, 2018
The role of oxidative stress in activity of anticancer thiosemicarbazonesKatarzyna Malarz, Anna Mrozek-Wilczkiewicz, Maciej Serda, et al.
Scientific Reports|January 16, 2020
Glycofullerenes as non-receptor tyrosine kinase inhibitors- towards better nanotherapeutics for pancreatic cancer treatmentMaciej Serda, Katarzyna Malarz, Anna Mrozek-Wilczkiewicz, et al.
Pageof 4